Sharon Reynolds, NP
Gerontology · Montgomery, ALNPI 1821563768
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Sumitomo Pharma America, Inc. at 36.9% of the total. 2025 is the largest year on record at $478, 2.5 times the $194 reported in 2021.
Across 87 payments — averaging $20.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$657
- Astellas Pharma US Inc$135
- Endo USA, Inc.$123
- Bayer$94
- Endo Pharmaceuticals Inc.$92
- AbbVie$87
- plus $595 from 19 others
What the payments were for
- Food & beverage$1,62291%
- Education$1609%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 40 | $657 |
| Astellas Pharma US Inc | 3 | $135 |
| Endo USA, Inc. | 5 | $123 |
| Bayer | 4 | $94 |
| Endo Pharmaceuticals Inc. | 4 | $92 |
| AbbVie | 4 | $87 |
| Amgen | 1 | $65 |
| Progenics Pharmaceuticals, Inc. | 3 | $61 |
| Johnson & Johnson | 2 | $52 |
| Urovant Sciences Inc | 2 | $45 |
| Antares Pharma, Inc. | 2 | $44 |
| Myovant Sciences Inc. | 2 | $39 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $38 |
| Biodelivery Sciences International, Inc. | 2 | $38 |
| Innovation Technologies Inc | 1 | $24 |
| 180 Medical, Inc. | 1 | $23 |
| Incyte Corporation | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Deciphera Pharmaceuticals Inc. | 1 | $17 |
| Pfizer | 1 | $17 |
| Sanofi | 1 | $17 |
| Bristol Myers Squibb | 1 | $13 |
How this compares
$1,782 in reported general payments places this provider in the 70th percentile of 143 gerontology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 118 | $88,865 |
| GemtesaVibegron | 37 | $30,488 |
| Tamsulosin Hcl | 392 | $9,336 |
| Trimethoprim | 70 | $2,121 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 157 | $1,553 |
| Doxycycline Hyclate | 163 | $1,439 |
| NitrofurantoinNitrofurantoin Macrocrystal | 48 | $1,329 |
| Silodosin | 12 | $1,157 |
| Terazosin Hcl | 34 | $965 |
| Dutasteride | 16 | $804 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 30 | $796 |
| Finasteride | 62 | $767 |
| CefuroximeCefuroxime Axetil | 50 | $676 |
| Nystatin | 11 | $491 |
| Ciprofloxacin Hcl | 63 | $396 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $135 | $88,865118 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $657 | $30,48837 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 143 gerontology providers in Alabama.
Other gerontology in Montgomery
- Ryan ShannonMontgomery$66K
- Sari CapiloutoMontgomery$9K
- Kristen OsborneMontgomery$5K
- Jawaneka EllersonMontgomery$2K
- Ashley PowellMontgomery$2K
- Rakiya AdedijiMontgomery$1K
- Bradley HammMontgomery$1K
- Heather CulliganMontgomery$889
- Claire BruceHuntsville$12K
- Michelle SanfordMobile$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.